Biotechnology

Filter

Current filters:

None

Popular Filters

1890 to 1914 of 2375 results

Pharma industry calls for broad-based cooperation to fight on-line sales of counterfeit medicines

24-07-2012

The global pharmaceutical industry unveiled recommendations this week to tackle the growing public health…

BiotechnologyGenericsGlobalMarkets & MarketingPharmaceuticalRegulation

US govt plans innovative public-private partnerships to turn the tide in fight against HIV/AIDS

23-07-2012

In a speech at the opening session of the XIX International AIDS Conference (AIDS 2012) in Washington…

Anti-viralsBiotechnologyHealthcareNorth AmericaPharmaceutical

Onyx soars as FDA approves Kyprolis for multiple myeloma

23-07-2012

Shares of US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) leapt 11.7% to $76.38 on Friday, after…

BiotechnologyKyprolisNorth AmericaOncologyOnyx PharmaceuticalsRegulation

Synergy Pharma and Callisto enter merger accord

22-07-2012

USA-based biopharma groups Synergy Pharmaceuticals (Nasdaq: SGYP) and Callisto Pharmaceuticals (OTCBB:…

BiotechnologyCallisto PharmaceuticalsMergers & AcquisitionsSynergy Pharmaceuticals

Barriers to overcome in lupus drug development

22-07-2012

It has taken the lupus research community over 50 years to produce a new therapy. Although it is now…

Anthera PharmaceuticalsBenlystaBiotechnologyblisibimodGlaxoSmithKlineImmunologicalsPharmaceuticalResearch

Actelion hikes earnings outlook despite lower sales

20-07-2012

Switzerland-based Actelion (ATLN: VX), Europe's largest biotech company, reported first-half 2012 financial…

ActelionBiotechnologyFinancial

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

SYGNIS and GENETRIX to combine subsidiary X-Pol business

19-07-2012

German biotech firms SYGNIS Pharma AG (Frankfurt: LIOK) and GENETRIX have signed a binding term sheet…

BiotechnologyGENETRIXMergers & AcquisitionsQualiphiSYGNIS Pharma

EU Commission proposes to revamp rules on clinical trials to make Europe more attractive for research

18-07-2012

With the aim of boosting clinical research in Europe by simplifying the rules for conducting clinical…

BiotechnologyEuropePharmaceuticalRegulationResearch

EMA consults on pharmacovigilance changes to medicines information

17-07-2012

The European Medicines Agency has launched a public consultation on the changes to the product information…

BiotechnologyEuropePharmaceuticalRegulation

Human Genome capitulates, accepting raised offer from GlaxoSmithKline

17-07-2012

Confirming weekend rumors (The Pharma Letter July 16), UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

FDA approves Truvada, first drug for reducing the risk of sexually acquired HIV infection

17-07-2012

Despite protests from consumer groups such as the AIDS Healthcare Foundation (AHF), the US Food and Drug…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

Genmab in collaboration with Janssen for DuoBody platform

16-07-2012

Denmark-based Genmab A/S (OMX: GEN) says it has entered into a collaboration with Janssen Biotech, a…

BiotechnologyDuoBodyGenmabJanssen BiotechJohnson & JohnsonLicensingNovartisPharmaceutical

BB Biotech rejects privatization proposal by Vontobel Group

16-07-2012

Swiss biotechnology investment fund BB Biotech (SIX: BION) has confirmed that Vontobel Group has made…

BB BiotechBiotechnologyEuropeFinancialMergers & AcquisitionsVontobel

Grifols acquires 40% of Spanish biotech firm VCN Bioscience

16-07-2012

Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer,…

BiotechnologyGrifolsMergers & AcquisitionsOncologyVCN Bioscience

UK's NICE launches new medicines advisory service

15-07-2012

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) last Friday launched…

Antibiotics and Infectious diseasesAstellas PharmaBiotechnologyDificlirEuropeGenericsPharmaceuticalRegulation

US drugmakers have almost 200 medicines in development for mental illnesses

15-07-2012

Research-based biopharmaceutical companies in the USA are developing 187 innovative medicines to help…

BiotechnologyNeurologicalNorth AmericaPharmaceuticalResearch

Global medicines spending set to rebound, reaching nearly $1.2 trillion by 2016, says IMS

13-07-2012

Following several years of slowing growth, the global market for medicines is poised to rebound from…

BiotechnologyGenericsGlobalHealthcareMarkets & MarketingPatentsPharmaceutical

Actelion announces cost saving initiative; Ipsen to hang on to Dreux

12-07-2012

Europe largest biotech firm, Actelion (SIX: ATLN) this morning said it has launched a cost saving initiative…

ActelionBiotechnologyEuropeFinancialIpsenPharmaceutical

US patients get faster access to more cancer drugs than Europeans, says Tufts

11-07-2012

Cancer patients in the USA get faster access to more oncology drugs to treat their disease than patients…

BiotechnologyEuropeHealthcareNorth AmericaOncologyPharmaceuticalPricingRegulation

1890 to 1914 of 2375 results

Back to top